Tile Shop Holdings, Inc. (NASDAQ:TTSH) Q3 2023 Earnings Conference Call November 2, 2023 9:00 AM ET Company Participants Mark Davis – Vice President, Investor
Deals and Financings Jiangsu Hengrui Pharma out-licensed global rights (ex-China) for its next-gen PARP1 inhibitor to Germany’s Merck KGaA (OTCPK:MKGAF) for a $170 million
Kennedy-Wilson Holdings, Inc. (NYSE:KW) Q3 2023 Earnings Conference Call November 2, 2023 12:00 PM ET Company Participants Daven Bhavsar – Head, Investor Relations Bill
Palomar Holdings, Inc. (NASDAQ:PLMR) Q3 2023 Earnings Conference Call November 2, 2023 12:00 PM ET Company Participants Chris Uchida – CFO McDonald Armstrong –
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands